Figure 2.

Age and fractional β-cell area percentage for nondiabetic subjects with Down syndrome (DS) and age-matched nondiabetic controls. (A) In each of the 3 defined age brackets, no difference was found between the ages of the Down syndrome group and the ages of the control group (Down syndrome vs control, age <5 years, 0.54 ± 0.14 vs 0.57 ± 0.13 years; age 5 to 15 years, 9.20 ± 1.28 vs 9.60 ± 1.40 years; age >15 years, 45.60 ± 4.52 vs 40.45 ± 4.53 years). (B) No difference was found in the fractional β-cell area between the subjects with Down syndrome and the control subjects in the 3 defined age brackets studied (Down syndrome vs control, age <5 years, 2.64% ± 0.36% vs 2.86% ± 0.37%; age 5 to 15 years, 2.02% ± 0.28% vs 1.84% ± 0.52%; age >15 years, 1.65% ± 0.29% vs 1.99% ± 0.24%).